(2-Chloro-5-methylpyridin-3-yl)methanamine hydrochloride, 97+%, 1g

1-Amino-4-hydroxyanthracene-9,10-dione, 97.0%, 250mg

3-Bromomethyl-benzenesulfonamide, 95.0%, 1g

4-Chloro-7-methoxy-quinoline, 97.0%, 5g

(2-methyl-1-oxo-2,3-dihydro-1H-isoindol-5-yl)boronic acid, 95.0%, 1g

2,2,2-Trifluoroacetic acid compound with 7-azaspiro[3.5]nonane-2-carboxylic acid (1:1), 98%, 100mg

Filtres pour seringues Minisart® NML avec marquage CE Non stérile, 0,45 µm, Luer Lock mâle, 500 pièce(s)

Ethyl 5-(2,3,4,5-tetrafluorophenyl)-5-oxovalerate, 97.0%, 1g

2-Methoxy-3-methylbenzaldehyde, 95.0%, 25g

N-Boc-5-Hydroxyindoline, 97.0%, 250mg

11-Phenylundecanoic acid, 98%, 5g

9-Bromo-9,10-dihydro-9,10-ethenoanthracene>98.0%(GC)5g

(2R,3R,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98%, 25g